Drug Development and Clinical Trials for Lymphoma and CLL/SLL

Webinars are hour-long interactive programs discussing the diagnosis and treatment of specific lymphoma subtypes and key research and treatment updates. Webinars feature a presentation from the featured expert, with the remainder of the time allocated to an extensive Q&A session.

Date: Thursday, September 4, 2025

Time: 1:00 – 2:00 PM ET

This program is hosted virtually on Zoom and can be accessed online and over the phone. Access instructions will be emailed after registration.

Program Overview

What are the Phases of Drug Development?
Responsibilities of the Food and Drug Administration (FDA)
The Role of Clinical Trials in Treating Lymphoma and CLL/SLL
The Lymphoma Research Foundation’s Clinical Trials Information Service
Question and Answer Session

Featuring

Andrew M. Evens, DO, MSc, MBA
Chair, Scientific Advisory Board
Learn more about Dr. Evens >

Gina Aracena
Director of Support Services and Patient Education
Lymphoma Research Foundation

Register here

You may also register by calling or emailing our Helpline at 800-500-9976 or lymphoma@lymphoma.org.

This program is for patients, survivors, care partners, and program supporters. If you are a pharmaceutical industry professional who is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.

Patient Education Program Disclaimer

Program Supporters

This program is supported through unrestricted educational grants from:

Webinars